Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ginkgo Bioworks
DNA
|
+$4.13B |
| 2 |
Humana
HUM
|
+$1.03B |
| 3 |
Parker-Hannifin
PH
|
+$724M |
| 4 |
McDonald's
MCD
|
+$714M |
| 5 |
Brookfield
BN
|
+$696M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$936M |
| 2 |
Aon
AON
|
+$693M |
| 3 |
Palo Alto Networks
PANW
|
+$576M |
| 4 |
ServiceNow
NOW
|
+$559M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$455M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.33% |
| 2 | Technology | 18.92% |
| 3 | Industrials | 11.99% |
| 4 | Consumer Discretionary | 11.25% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTM
51
ZoomInfo Technologies
GTM
$1.16B
| $236M | 0.65% |
3,859,159
+1,477,885
| +62% | +$88.4M |
|
52
Canadian Pacific Kansas City
CP
$85B
| $224M | 0.62% |
+3,447,633
| New | +$246M |
|
53
Tenet Healthcare
THC
$22.6B
| $223M | 0.61% |
3,353,856
+1,074,674
| +47% | +$76.2M |
|
54
Labcorp
LH
$27.3B
| $223M | 0.61% |
921,592
-677,062
| -42% | -$171M |
|
55
Match Group
MTCH
$9.38B
| $214M | 0.59% |
1,365,007
-991,399
| -42% | -$151M |
|
56
Procept Biorobotics
PRCT
$1.24B
| $187M | 0.51% |
+4,907,892
| New | +$188M |
|
57
Ingersoll Rand
IR
$31.2B
| $184M | 0.5% |
3,641,009
-2,776,245
| -43% | -$141M |
|
|
INBX
58
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $177M | 0.48% |
5,305,866
| – | – |
|
|
MRSH
59
Marsh
MRSH
$91.6B
| $175M | 0.48% |
1,156,185
-901,276
| -44% | -$136M |
|
60
Intellia Therapeutics
NTLA
$1.8B
| $172M | 0.47% |
1,279,531
+304,439
| +31% | +$46.1M |
|
|
CTLT
61
DELISTED
CATALENT, INC.
CTLT
| $155M | 0.42% |
1,163,034
+44,569
| +4% | +$5.57M |
|
62
Royalty Pharma
RPRX
$27.3B
| $150M | 0.41% |
4,140,508
+901,854
| +28% | +$35M |
|
63
Zentalis Pharmaceuticals
ZNTL
$363M
| $141M | 0.39% |
2,118,284
-281,000
| -12% | -$16.2M |
|
64
Acadia Healthcare
ACHC
$2.59B
| $134M | 0.37% |
2,102,758
+42,633
| +2% | +$2.69M |
|
65
HDFC Bank
HDB
$121B
| $123M | 0.34% |
+3,358,260
| New | +$125M |
|
66
PVH
PVH
$3.62B
| $119M | 0.33% |
1,161,695
+522,221
| +82% | +$56.2M |
|
|
KRTX
67
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $106M | 0.29% |
868,696
+46,231
| +6% | +$5.34M |
|
68
4D Molecular Therapeutics
FDMT
$875M
| $106M | 0.29% |
3,937,914
| – | – |
|
|
69
Thermo Fisher Scientific
TMO
$233B
| $104M | 0.29% |
182,237
-829,164
| -82% | -$455M |
|
70
AdaptHealth
AHCO
$751M
| $94.9M | 0.26% |
4,074,029
+977,601
| +32% | +$23.6M |
|
71
Align Technology
ALGN
$11.5B
| $74.2M | 0.2% |
111,570
-292,517
| -72% | -$199M |
|
|
OLPX
72
DELISTED
Olaplex Holdings
OLPX
| $74M | 0.2% |
+3,022,372
| New | +$74M |
|
73
Rallybio
RLYB
$89.4M
| $73.7M | 0.2% |
+524,347
| New | +$61.5M |
|
74
Charles River Laboratories
CRL
$14.1B
| $73.2M | 0.2% |
177,403
-174,465
| -50% | -$72.5M |
|
75
Illumina
ILMN
$33.1B
| $63M | 0.17% |
+159,668
| New | +$73.4M |
|
Similar funds
Andreas Halvorsen's Q3 2021 Portfolio in Review
As of Q3 2021, Andreas Halvorsen held 113 positions worth $36.5B, up 11% from $33B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Andreas Halvorsen deployed $5.21B of net new capital in Q3 2021, opening 25 new positions and adding to 26 existing holdings. Its largest new stake was Ginkgo Bioworks: 8,476,379 shares worth $3.93B.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Amazon, an estimated $936M trimmed.
- Andreas Halvorsen's largest Q3 2021 buy was Ginkgo Bioworks: 8,476,379 shares worth $3.93B.
- Andreas Halvorsen added most to Humana in Q3 2021, an estimated $1.03B increase.
- Andreas Halvorsen's biggest Q3 2021 reduction was Amazon, cutting an estimated $936M.
- Andreas Halvorsen fully exited Aon in Q3 2021, selling an estimated $693M.
- Andreas Halvorsen's ten largest holdings make up 39% of its $36.5B portfolio in Q3 2021.
- Andreas Halvorsen opened 25 new positions and closed 17 in Q3 2021.
- Andreas Halvorsen's portfolio value rose 11% quarter-over-quarter to $36.5B.
Based on Viking Global Investors's 13F filing for Q3 2021, filed 15 Nov 2021.